BridgeMD
Tests treatment safety and results for Chest Pain
Official title Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During S-ICD Implantation Procedure.
ClinicalTrials.gov ID: NCT06520150
What this study is testing
What is Ropivacaine 0.125% Injectable Solution +Lignocaine 0,25% Injectable Solution?
Ropivacaine 0.125% Injectable Solution +Lignocaine 0,25% Injectable Solution is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for chest pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Our study consists of a combination of regional blockade ('local' anesthesia) of the anterior and lateral chest wall in the form of a thin needle prick and the supply of local anesthetic drugs to the area of the relevant chest wall structures to exclude all stimuli, including pain from the operative site. A short-acting analgesic and sedative drug will be administered intravenously throughout the procedure - in a dose that allows the required contact between the patient and the anesthetist.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- patients aged 18-90 years requiring S-ICD implantation for cardiac indications,
- high risk of anesthesia (ASA II or higher), patients giving informed consent to participate in the study.
You likely can't join if
- absolute contraindications to regional anesthesia such as generalized coagulation disorders, inflammation at the site of anesthesia, allergy to the...
- lack of consent of the patient for the conducted procedure,
- inability to cooperate with the patient - such as severe mental retardation, unregulated mental illness with motor agitation, advanced...
- inability to give informed consent to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Wroclaw, Lower Silesian Voivodeship, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wroclaw, Lower Silesian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.